Suma Genomics Private Limited - Company Profile

It is a healthcare private limited company based in Devanahalli, Karnataka, India, established in 2019.
2019 Devanahalli, Karnataka, India Active
Last Updated:
Access Report
About Suma Genomics Private Limited

Suma Genomics Private Limited, a active private limited company, was established on 04 January 2019 in Devanahalli, Karnataka, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85100KA2019PTC120034. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Girisha Katta Mohan (Director), Nagabushan Swamy Channaiah (Additional Director), Hunasagatta Gurappaiah Vijayamma (Additional Director). Past directors included Sri Lakshmi Bhavani Gandham, Chakshu Chaudhry, Katta Kumar Mohan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit 111, First Floor, Arcade Mall, Brigade Orchards, Devanahalli, Bengaluru Rural District,, Devanahalli, Karnataka, 562110.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100KA2019PTC120034

  • Registration Number

    120034

  • Incorporation Date

    04 January 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 7 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 138.78%
  • Profit Growth **** 17454.86%
  • Ebitda **** 218.14%
  • Net Worth 49.36%
  • Total Assets **** 64.26%
Company report

Suma Genomics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Suma Genomics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Suma Genomics Private Limited?
Current Directors
Name Designation Appointment Date Status
Girisha Katta Mohan Director 04 Jan 2019 Current
Nagabushan Swamy Channaiah Additional Director 05 Nov 2025 Current
Hunasagatta Gurappaiah Vijayamma Additional Director 05 Nov 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 26 Jul 2023 Past
Pramod Abcsdd Director - Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Suma Genomics.

Suma Genomics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 138.78% increase. The company also saw a substantial improvement in profitability, with a 17454.86% increase in profit. The company's net worth Soared by an impressive increase of 49.36%.

Suma Genomics revenue growth over time
Suma Genomics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 138.78%
*******
*******
*******
*******
Revenue from Operations
*******
 138.81%
*******
*******
*******
*******
Total Assets
*******
 64.26%
*******
*******
*******
*******
Profit or Loss
*******
 17454.86%
*******
*******
*******
*******
Net Worth
*******
 49.36%
*******
*******
*******
*******
EBITDA
*******
 218.14%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Suma Genomics?

In 2022, Suma Genomics had a public holding of 3.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Suma Genomics?

Unlock and access historical data on people associated with Suma Genomics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Suma Genomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suma Genomics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Suma Genomics
Recent Activity within the Organization
  • Director Appointment

    Nagabushan Swamy Channaiah was appointed as a Additional Director was appointed as a Additional Director on 05 Nov 2025 & has been associated with this company since 3 months 6 days . was recorded as a recent event.

  • Director Appointment

    Progress on Hunasagatta Gurappaiah Vijayamma was appointed as a Additional Director was appointed as a Additional Director on 05 Nov 2025 & has been associated with this company since 3 months 6 days . was documented.

  • Annual General Meeting

    Progress on Suma Genomics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Suma Genomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    Girisha Katta Mohan was appointed as a Director was appointed as a Director on 04 Jan 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Progress on Suma Genomics Private Limited was registered on 04 Jan 2019 with Roc Bangalore & aged 7 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Suma Genomics Private Limited?

The CIN of Suma Genomics Private Limited is U85100KA2019PTC120034.

Where is Suma Genomics Private Limited headquartered?

Suma Genomics Private Limited is headquartered at Unit 111, First Floor, Arcade Mall, Brigade Orchards, Devanahalli, Bengaluru Rural District,, Devanahalli, Karnataka, 562110.

When was Suma Genomics Private Limited incorporated?

Suma Genomics Private Limited was incorporated on 04 January 2019.

Who are the current directors of Suma Genomics Private Limited?

The current directors of Suma Genomics Private Limited are

What is the primary industry of Suma Genomics Private Limited?

The primary industry of Suma Genomics Private Limited is Hospital And Medical Care.

Is Suma Genomics Private Limited a listed company?

Suma Genomics Private Limited is unlisted.

What is the capital structure of Suma Genomics Private Limited?

The authorized capital of Suma Genomics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available